Menu
Search
|

Menu

Close
X

NantHealth Inc NH.OQ (NASDAQ Stock Exchange Global Select Market)

3.11 USD
-- (--)
As of Feb 20
chart
Previous Close 3.11
Open --
Volume --
3m Avg Volume 51,758
Today’s High --
Today’s Low --
52 Week High 7.92
52 Week Low 2.60
Shares Outstanding (mil) 108.33
Market Capitalization (mil) 336.91
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.33 Mean rating from 3 analysts

KEY STATS

Revenue (mm, USD)
FY17
70
FY16
96
FY15
58
EPS (USD)
FY17
-1.112
FY16
-1.547
FY15
-0.596
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
35.64
Price to Sales (TTM)
vs sector
3.81
8.67
Price to Book (MRQ)
vs sector
1.59
5.21
Price to Cash Flow (TTM)
vs sector
--
26.03
Total Debt to Equity (MRQ)
vs sector
97.88
15.38
LT Debt to Equity (MRQ)
vs sector
97.88
12.01
Return on Investment (TTM)
vs sector
-33.28
13.57
Return on Equity (TTM)
vs sector
-52.66
15.19

EXECUTIVE LEADERSHIP

Patrick Soon-Shiong
Chairman of the Board, Chief Executive Officer, Founder, Since 2016
Salary: --
Bonus: --
Paul Holt
Chief Financial Officer, Since 2015
Salary: $360,433.00
Bonus: $98,056.00
Michael Blaszyk
Independent Director, Since 2016
Salary: --
Bonus: --
Mark Burnett
Independent Director, Since 2016
Salary: --
Bonus: --
Kirk Calhoun
Independent Director, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

9920 JEFFERSON BLVD
CULVER CITY   CA   90232-3506

Phone: +1310.8537888

NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient's tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

SPONSORED STORIES